Home >> Signaling Pathways >> Chromatin/Epigenetics >> HIF

HIF

Hypoxia inducible factors (HIFs) are heterodimeric proteins belonging to the basic helix-loop-helix-PAS (bHLH/PAS) family of transcription factors that mediate the primary transcriptional response to stress caused by hypoxia (accessible O2 level < 2%). HIFs are characterized by containing two subunits, including O2-labile α subunit (HIFα) and constitutively expressed β subnit (HIFβ). Mammalian HIFα consists of three isoforms, including HIF1α, HIF2α and HIF3α, which play an essential role in the regulation of HIF activity by O2 availability. Under normal O2 tension, HIFα is hydroxylated at the two conserved proline residues within the O2-dependent degradation (ODD) domain by prolylhydroxylase domain proteins (PHDs) and undergoes proteosomal degradation catalyzed by a complex formed by E3 ubiquitin ligase and the von Hippel-Lindau protein (pVHL); while, under hypoxia, HIFα stabilizes with PHDs being deactivated and hence induce transcription of genes with adaptive functions.

Products for  HIF

  1. Cat.No. Product Name Information
  2. GC69794 (Rac)-Arnebin 1

    (Rac)-Arnebin 1 is the racemic form of β,β-Dimethylacrylalkannin and/or β,β-Dimethylacrylshikonin. These compounds are naphthoquinones isolated from plants in the Lithospermum genus, with β,β-Dimethylacrylshikonin exhibiting anti-tumor activity.

    (Rac)-Arnebin 1  Chemical Structure
  3. GC65133 (S,R,S)-AHPC-C5-COOH (S,R,S)-AHPC-C5-COOH (VH032-C5-COOH) is a synthesized?E3 ligase ligand-linker conjugate, contains the VH032 VHL-based ligand and a linker to form PROTACs. VH-032 is a selective and potent inhibitor of VHL/HIF-1α interaction with a Kd of 185 nM, has the potential for the study of anemia and ischemic diseases. (S,R,S)-AHPC-C5-COOH  Chemical Structure
  4. GC61949 1,4-DPCA ethyl ester 1,4-DPCA ethyl ester is the ethyl ester of 1,4-DPCA and can inhibit factor inhibiting HIF (FIH). 1,4-DPCA ethyl ester  Chemical Structure
  5. GC16195 2,4-DPD Diethyl pyridine-2,4-dicarb is a potent prolyl 4-hydroxylase-directed proinhibitor. 2,4-DPD  Chemical Structure
  6. GC15084 2-Methoxyestradiol (2-MeOE2) 2-Methoxyestradiol (2-MeOE2/2-Me) is a HIF-1α inhibitor that inhibits HIF-1α accumulation and HIF transcriptional activity. 2-Methoxyestradiol can trigger p53-induced apoptosis and has potential antitumor activity.. 2-Methoxyestradiol (2-MeOE2)  Chemical Structure
  7. GC14282 3-acetyl-11-keto-β-Boswellic Acid 3-acetyl-11-keto-β-Boswellic Acid (Acetyl-11-keto-β-boswellic acid) is an active triterpenoid compound from the extract of Boswellia serrate and a novel Nrf2 activator. 3-acetyl-11-keto-β-Boswellic Acid  Chemical Structure
  8. GC35230 Acetylarenobufagin Acetylarenobufagin is a steroidal hypoxia inducible factor-1 (HIF-I) modulator. Acetylarenobufagin  Chemical Structure
  9. GC32083 Acriflavine Acriflavine is a fluorescent dye for labeling high molecular weight RNA. Acriflavine  Chemical Structure
  10. GC62354 Acriflavine hydrochloride Acriflavine hydrochloride (Acriflavinium chloride hydrochloride) is a fluorescent acridine dye that can be used to label nucleic acid. Acriflavine hydrochloride  Chemical Structure
  11. GC12487 Adaptaquin HIF-prolyl hydroxylase-2 (PHD2) inhibitor Adaptaquin  Chemical Structure
  12. GC33416 AFP464 AFP464 (NSC710464 free base), is an active HIF-1α inhibitor with an IC50 of 0.25 μM, also is a potent aryl hydrocarbon receptor (AhR) activator. AFP464  Chemical Structure
  13. GC62277 AKB-6899 Ro24-7429 is a potent and orally active HIV-1 transactivator protein Tat antagonist. Ro24-7429 is also a runt-related transcription factor 1 (RUNX1) inhibitor. Ro24-7429 has anti-HIV, antifibrotic and anti-inflammatory effects. AKB-6899  Chemical Structure
  14. GC42785 Amifostine (hydrate) Amifostine (hydrate) (WR2721 trihydrate) is a broad-spectrum cytoprotective agent and a radioprotector. Amifostine (hydrate) selectively protects normal tissues from damage caused by radiation and chemotherapy. Amifostine (hydrate) is potent hypoxia-inducible factor-α1 (HIF-α1) and p53 inducer. Amifostine (hydrate) protects cells from damage by scavenging oxygen-derived free radicals. Amifostine (hydrate) reduces renal toxicity and has antiangiogenic action. Amifostine (hydrate)  Chemical Structure
  15. GC12698 BAY 87-2243 A HIF-1 inhibitor,potent and selective BAY 87-2243  Chemical Structure
  16. GC17405 Chetomin An inhibitor of HIF signaling Chetomin  Chemical Structure
  17. GN10518 Chitosamine hydrochloride Chitosamine hydrochloride  Chemical Structure
  18. GN10308 Chlorogenic acid

    Chlorogenic acid is a major phenolic compound in coffee and tea. 

    Chlorogenic acid  Chemical Structure
  19. GC16647 Daprodustat(GSK1278863) Daprodustat(GSK1278863) (GSK1278863) is an orally active hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor being developed for the treatment of anemia associated with chronic kidney disease. Daprodustat(GSK1278863)  Chemical Structure
  20. GC68955 Deferoxamine

    Deferoxamine (Deferoxamine B) is an iron chelator (binding Fe(III) and many other metal cations), widely used to reduce the accumulation and deposition of iron in tissues. 

    Deferoxamine  Chemical Structure
  21. GC31230 Dencichin (Dencichine) Dencichin is a non-protein amino acid originally extracted from Panax notoginseng, and can inhibit HIF-prolyl hydroxylase-2 (PHD-2) activity. Dencichin (Dencichine)  Chemical Structure
  22. GC38767 Deoxyshikonin A natural products with anti-tumor activity Deoxyshikonin  Chemical Structure
  23. GC32449 Desidustat An inhibitor of HIF-PH Desidustat  Chemical Structure
  24. GC18236 Echinomycin An inhibitor of HIF1mediated gene transcription Echinomycin  Chemical Structure
  25. GC33043 EL-102 EL-102 is a hypoxia-induced factor 1 (Hif1α) inhibitor. EL-102 induces apoptosis, inhibits tubulin polymerisation and shows activities against prostate cancer. EL-102 can be used for the research of cancer. EL-102  Chemical Structure
  26. GC33634 Enarodustat (JTZ-951) Enarodustat (JTZ-951) is a potent and orally active hypoxia-inducible factor prolyl hydroxylase inhibitor, with an EC50 of 0.22 μM. Enarodustat (JTZ-951)  Chemical Structure
  27. GC33170 ENMD-119 (ENMD 1198) ENMD-119 (ENMD 1198) (IRC-110160), an orally active microtubule destabilizing agent, is a 2-methoxyestradiol analogue with antiproliferative and antiangiogenic activity. ENMD-119 (ENMD 1198) is suitable for inhibiting HIF-1alpha and STAT3 in human HCC cells and leads to reduced tumor growth and vascularization. ENMD-119 (ENMD 1198)  Chemical Structure
  28. GC61669 Ethyl 3,4-dihydroxybenzoate Ethyl 3,4-dihydroxybenzoate (Ethyl protocatechuate), an antioxidant, is a prolyl-hydroxylase inhibitor found in the testa of peanut seeds. Ethyl 3,4-dihydroxybenzoate  Chemical Structure
  29. GC13139 FG-4592 (ASP1517) An inhibitor of HIF-PH enzymes FG-4592 (ASP1517)  Chemical Structure
  30. GC16638 FG2216 HIF-prolyl hydroxylase inhibitor FG2216  Chemical Structure
  31. GC50537 FM19G11 A HIF α-subunit inhibitor FM19G11  Chemical Structure
  32. GC38044 Fraxinellone Fraxinellone  Chemical Structure
  33. GC30263 Glucosamine (D-Glucosamine) Glucosamine (D-Glucosamine) (D-Glucosamine (D-Glucosamine)) is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids, is used as a dietary supplement. Glucosamine (D-Glucosamine)  Chemical Structure
  34. GN10669 Glucosamine sulfate Glucosamine sulfate  Chemical Structure
  35. GC34595 GN44028 A HIF-1 inhibitor GN44028  Chemical Structure
  36. GC40918 Gramicidin A Gramicidin A is a peptide component of gramicidin, an antibiotic mixture originally isolated from B. Gramicidin A  Chemical Structure
  37. GC39146 HIF-1 inhibitor-1 An inhibitor of HIF-1 signaling HIF-1 inhibitor-1  Chemical Structure
  38. GC66464 HIF-1α-IN-2 HIF-1α-IN-2 is an effective HIF-1α inhibitor with anticancer potencies (IC50s of 28 nM and 15 nM in MDA-MB-231 and MiaPaCa-2 cells, respectively). HIF-1α-IN-2 suppresses HIF-1α expression by blocking transcription and protein translation. HIF-1α-IN-2  Chemical Structure
  39. GC62584 HIF-2α-IN-2 HIF-2α-IN-2 is a hypoxia-inducible factors (HIF-2α) inhibitor extracted from patent WO2015035223A1, Compound 232, has an IC50 of 16 nM in scintillation proximity assay (SPA). HIF-2α-IN-2  Chemical Structure
  40. GC62418 HIF-2α-IN-3 HIF-2α-IN-3, an allosteric inhibitor of hypoxia inducible factor-2α (HIF-2α), exhibits an IC50 of 0.4 μM and a KD of 1.1 μM. Anticancer agent. HIF-2α-IN-3  Chemical Structure
  41. GC63678 HIF-2α-IN-4 HIF-2α-IN-4 is a potent inhibitor of hypoxia inducible factor-2α (HIF-2α) translation, with an IC50 of 5 μM. HIF-2α-IN-4 decreases both constitutive and hypoxia-induced HIF-2α protein expression. HIF-2α-IN-4 links its 5'UTR iron-responsive element to oxygen sensing. HIF-2α-IN-4  Chemical Structure
  42. GC31358 HIF-2α-IN-1 HIF-2α-IN-1 is a HIF-2α inhibitor has an IC50 of less than 500 nM in HIF-2α scintillation proximity assay. HIF-2α-IN-1  Chemical Structure
  43. GC67941 HIF-PHD-IN-1 HIF-PHD-IN-1  Chemical Structure
  44. GC65570 HIF1-IN-3 HIF1-IN-3 (compound F4) is a potent HIF1 inhibitor with an EC50 value of 0.9 μM. HIF1-IN-3 can be used for researching anticancer. HIF1-IN-3  Chemical Structure
  45. GC11767 Hydralazine HCl Hydralazine HCl is a orally active antihypertensive agent, reduces peripheral resistance directly by relaxing the smooth muscle cell layer in arterial vessel. Hydralazine HCl  Chemical Structure
  46. GC60919 Hydroxycitric acid tripotassium hydrate Hydroxycitric acid tripotassium hydrate (Potassium citrate monohydrate) is the major active ingredient of Garcinia cambogia. Hydroxycitric acid tripotassium hydrate  Chemical Structure
  47. GC32948 IDF-11774 A novel HIF-1 inhibitor IDF-11774  Chemical Structure
  48. GC13018 IOX2(Glycine) A selective PHD2 inhibitor IOX2(Glycine)  Chemical Structure
  49. GC12255 IOX4 PHD2 inhibitor IOX4  Chemical Structure
  50. GC63828 Izilendustat Izilendustat is a potent inhibitor of prolyl hydroxylase which can stabilize hypoxia inducible factor- 1 alpha (HIF- lα) and hypoxia inducible factor-2 (HIF-2). Izilendustat  Chemical Structure
  51. GC15379 JNJ-42041935 Hypoxia-inducible factor (HIF) prolyl hydroxylase (PHD) inhibitor JNJ-42041935  Chemical Structure
  52. GC13141 KC7F2 An inhibitor of HIF-1a protein synthesis KC7F2  Chemical Structure
  53. GC32724 LW6 (HIF-1α inhibitor) LW6 (HIF-1α inhibitor) (HIF-1α inhibitor) is a novel HIF-1 inhibitor with an IC50 of 4.4 μM. LW6 (HIF-1α inhibitor) decreases HIF-1α protein expression without affecting HIF-1β expression. LW6 (HIF-1α inhibitor)  Chemical Structure
  54. GC64945 M1001 M1001 is a weak hypoxia-inducible factor-2α (HIF-2α) agonist. M1001 can bind to the HIF-2α PAS-B domain, with a Kd of 667 nM. M1001 can be used in chronic kidney disease research. M1001  Chemical Structure
  55. GC65046 M1002 M1002 is a hypoxia-inducible factor-2 (HIF-2) agonist, and can enhance the expression of HIF-2 target genes. M1002 shows synergy with prolyl-hydroxylase domain (PHD) inhibitors. M1002  Chemical Structure
  56. GC19251 MK-8617 MK-8617 is an orally active pan-inhibitor of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) with an IC50 of 1 nM for PHD2. MK-8617  Chemical Structure
  57. GC14319 ML 228 A HIF pathway activator ML 228  Chemical Structure
  58. GC10046 Molidustat (BAY85-3934) Molidustat (BAY85-3934) (BAY 85-3934) is a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase (HIF-PH) with mean IC50 values of 480 nM for PHD1, 280 nM for PHD2, and 450 nM for PHD3. Molidustat (BAY85-3934)  Chemical Structure
  59. GC62406 Moracin O Moracin O is a 2-arylbenzofuran isolated from the Mori Cortex Radicis. Moracin O  Chemical Structure
  60. GC17358 Octyl-α-ketoglutarate prolyl hydroxylases (PHD) activator Octyl-α-ketoglutarate  Chemical Structure
  61. GC12821 Oltipraz Nrf2 activator;An antischistosomal agent Oltipraz  Chemical Structure
  62. GC41625 Oroxylin A

    Oroxylin A is a flavonoid that has been found in S.

    Oroxylin A  Chemical Structure
  63. GN10452 Paeoniflorin Paeoniflorin  Chemical Structure
  64. GC64584 PHD-1-IN-1 PHD-1-IN-1 is an orally active and potent HIF prolylhydroxylase domain-1 (PHD-1) inhibitor with an IC50 of 0.034 μM. PHD-1-IN-1  Chemical Structure
  65. GC41572 PRLX-93936

    PRLX-93936 is an analog of erastin that has antitumor activity.

    PRLX-93936  Chemical Structure
  66. GC32680 PT-2385 PT-2385 is a selective HIF-2α inhibitor with a Ki of less than 50 nM. PT-2385  Chemical Structure
  67. GC65333 PT2399 PT2399 is a potent and selective HIF-2α antagonist, which directly binds to HIF-2α PAS B domain with an IC50 of 6 nM. PT2399 displays potent antitumor activity in vivo. PT2399  Chemical Structure
  68. GC37034 PT2977 PT2977 (PT2977) is an orally active and selective HIF-2α inhibitor with an IC50 of 9 nM. PT2977, as a second-generation HIF-2α inhibitor, increases potency and improves pharmacokinetic profile. PT2977 is a potential treatment for clear cell renal cell carcinoma (ccRCC). PT2977  Chemical Structure
  69. GC11031 PX-478 2HCl

    PX-478 is a selective inhibitor that suppresses constitutive and hypoxia-induced HIF-1α levels.

    PX-478 2HCl  Chemical Structure
  70. GC37066 Rac-PT2399 A potent and specific HIF-2α inhibitor Rac-PT2399  Chemical Structure
  71. GC49190 Roxadustat-d5 An internal standard for the quantification of roxadustat Roxadustat-d5  Chemical Structure
  72. GC69956 Steppogenin

    Steppogenin is an effective inhibitor of HIF-1α and DLL4, with IC50 values of 0.56 and 8.46 μM, respectively. Steppogenin can be used for research on angiogenesis-related diseases such as solid tumors.

    Steppogenin  Chemical Structure
  73. GC32876 SYP-5 A HIF-1 inhibitor SYP-5  Chemical Structure
  74. GC50211 TAT-cyclo-CLLFVY Selective HIF-1 dimerization inhibitor TAT-cyclo-CLLFVY  Chemical Structure
  75. GC50128 TC-S 7009 High affinity and selective HIF-2α inhibitor TC-S 7009  Chemical Structure
  76. GC32945 THS-044 THS-044 binding stabilizes the HIF2α PAS-B folded state, for regulating HIF2 activity in endogenous and clinical settings. THS-044  Chemical Structure
  77. GC32228 Tilorone dihydrochloride An interferon-inducing antiviral agent Tilorone dihydrochloride  Chemical Structure
  78. GC49062 Tiopronin-d3 An internal standard for the quantification of tiopronin Tiopronin-d3  Chemical Structure
  79. GC37801 TM6089 TM6089 is a unique Prolyl Hydroxylase (PHD) inhibitor which stimulates HIF activity without iron chelation and induces angiogenesis and exerts organ protection against ischemia. TM6089  Chemical Structure
  80. GC31498 TP0463518

    TP0463518 is a potent hypoxia-inducible factor prolyl hydroxylases (PHDs) inhibitor

    TP0463518  Chemical Structure
  81. GC64001 TRC160334 TRC160334 is a hypoxia-inducible factor (HIF) hydroxylase inhibitor. TRC160334  Chemical Structure
  82. GC16811 Vadadustat HIF-PH inhibitor Vadadustat  Chemical Structure
  83. GC37889 VCE-004.8 VCE-004.8 (VCE-004.8) is an orally active, specific PPARγ and CB2 receptor dual agonist. VCE-004.8  Chemical Structure
  84. GC61863 Verucopeptin Verucopeptin is a potent?HIF-1 (IC50=0.22 μM) inhibitor and decreases the expression of HIF-1 target genes and HIF-1α protein levels. Verucopeptin strongly inhibits v-ATPase activity?by directly targeting the v-ATPase ATP6V1G subunit but not ATP1V1B2 or ATP6V1D. Verucopeptin exhibits antitumor activity against multidrug resistance (MDR)?cancers and can be used for cancer research. Verucopeptin  Chemical Structure
  85. GC37966 ZINC13466751 ZINC13466751 is a potent inhibitor of HIF-1α/von Hippel-Lindau interaction with an IC50 of 2.0 ?M. ZINC13466751  Chemical Structure

84 Item(s)

per page

Set Descending Direction